FOXP3 and asthma: Therefore, our present study suggested that it is likely that intraperitoneal administration of α‐GalCer prior to the development of asthma disorder, which can promote the generation of lung CD4+ FoxP3+ Treg cells by the activated iNKT cells, may have potential as a therapeutic method for asthma.